General Information of the Compound
Compound ID
CP0427299
Compound Name
1-(3-chlorobenzyl)-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridine
    Show/Hide
Structure
Formula
C20H19ClN2
Molecular Weight
322.839
Canonical SMILES
Clc1cccc(Cn2cc(c3CNCCc23)-c2ccccc2)c1
    Show/Hide
InChI
InChI=1S/C20H19ClN2/c21-17-8-4-5-15(11-17)13-23-14-19(16-6-2-1-3-7-16)18-12-22-10-9-20(18)23/h1-8,11,14,22H,9-10,12-13H2
    Show/Hide
InChIKey
CBWYBVLARINGQE-UHFFFAOYSA-N
Physicochemical Property
logP
4.5025
Rotatable Bonds
3
Heavy Atom Count
23
Polar Areas
16.96
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 53323534
ChEMBL ID
CHEMBL1644485
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 6600 nM
   TI
   LI
   LO
   TS